Meyer T

ORCID: 0000-0003-3425-4546 · 3 papers in corpus
other 2020
JAMA oncology ·doi:10.1001/jamaoncol.2020.0001

IMPORTANCE: The overall low survival rate of patients with lung cancer calls for improved detection tools to enable better treatment options and improved patient outcomes. Multivariable molecular signatures, such as blood-borne microRNA (mi…

other 2006
Molecular cancer ·doi:10.1186/1476-4598-5-30

BACKGROUND: Carcinogenesis is a multi-step process indicated by several genes up- or down-regulated during tumor progression. This study examined and identified differentially expressed genes in cutaneous squamous cell carcinoma (SCC). RES…

review 2000
British journal of cancer ·doi:10.1054/bjoc.2000.1174

Currently the only tumour marker to have a well-defined and validated role in the management of ovarian cancer is CA125. Changes in the level of CA125 can be used as a reliable indication of response or progression according to various crit…